Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase.

Background: Studies with large size samples on the liver histological changes of indeterminate phase chronic hepatitis B (CHB) patients were not previously conducted.

Aim: To assess the liver histological changes in the indeterminate phase CHB patients using liver biopsy.

Methods: The clinical and laboratory data of 1532 untreated CHB patients were collected, and all patients had least once liver biopsy from January 2015 to December 2021. The significant differences among different phases of CHB infection were compared with -test, and the risk factors of significant liver histological changes were analyzed by the multivariate logistic regression analysis.

Results: Among 1532 untreated CHB patients, 814 (53.13%) patients were in the indeterminate phase. Significant liver histological changes (defined as biopsy score ≥ G2 and/or ≥ S2) were found in 488/814 (59.95%) CHB patients in the indeterminate phase. Significant liver histological changes were significant differences among different age, platelets (PLTs), and alanine aminotransferase (ALT) subgroup in indeterminate patient. Multivariate logistic regression analysis indicated that age ≥ 40 years old [adjust odd risk (aOR), 1.44; 95% confidence interval (CI): 1.06-1.97; = 0.02], PLTs ≤ 150 × 10/L (aOR, 2.99; 95%CI: 1.85-4.83; < 0.0001), and ALT ≥ upper limits of normal (aOR, 1.48; 95%CI: 1.08, 2.05, = 0.0163) were independent risk factors for significant liver histological changes in CHB patients in the indeterminate phase.

Conclusion: Our results suggested that significant liver histological changes were not rare among the untreated CHB patients in indeterminate phase, and additional strategies are urgently required for the management of these patients.